Innovative and Targeted Cancer Therapies: Key technologies, new applications and leading players

The highly dynamic cancer market is creating a new age of discovery and innovation driven by molecular biology, oncogenomics and new methods in cell biology. Resultantly, cancer innovatives are not only the fastest growing segment within the cancer market, but the key drivers of sales growth across the pharmaceutical market as a whole.

These innovations will result in high value opportunities to develop newer and more effective therapies, ensuring companies can effectively respond to the increasing prevalence of cancer. Innovative and Targeted Cancer Therapies provides a detailed insight into both cancer therapeutics and diagnostics, to provide a clear vision of how the cancer market will develop over the next five years. It also identifies key alliance and partnering opportunities, highlighting companies with specialised capabilities in the discovery and the characterization of next-generation drug targets. Use this report to understand how the cancer market is developing, identify areas of unmet medical need and align your product pipeline to achieve clinical and commercial success.

Read more...

• Cancer Overview (19/05/2008)
• Molecular Targeted Cancer Therapies (19/05/2008)
• Innovations in Cancer (15/05/2008)

• Winning Product Launch Strategies (14/05/2008)
• Drug Repositioning Strategies (14/05/2008)
• Outlook for RNAi (14/05/2008)

• The Future of Biosimilars (14/05/2008)
• Cardiovascular Disease Management (14/05/2008)
• Nanotechnology (12/05/2008)
• The Future of Targeted Therapeutics (12/05/2008)
• Nosocomial Vaccines (12/05/2008)
• HRT for Menopausal Symptoms (12/05/2008)
• CNS Market Overview (12/05/2008)

---